logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9920135 B1

PDFFull Text
Date of Patent:
Mar. 20, 2018

Filed:

Jul. 30, 2014

Anti-human cd26 monoclonal antibody or antigen-binding fragment thereof

Applicant:

Juntendo Educational Foundation, Bunkyo-ku, JP;

Inventors:

Chikao Morimoto, Setagaya-ku, JP;

Ryo Hatano, Yokohama, JP;

Taketo Yamada, Suginami-ku, JP;

Kei Ohnuma, Shinagawa-ku, JP;

Assignee:

JUNTENDO EDUCATIONAL FOUNDATION, Bunkyo-ku, JP;

Attorney:

Oblon, McClelland, Maier & Neustadt, L.L.P.

Primary Examiner:

Misook Yu

Assistant Examiner:

Anne L Holleran

Int. Cl.
CPC ...
C07K 16/28 (2006.01); C07K 16/30 (2006.01); G01N 33/566 (2006.01); G01N 33/567 (2006.01); C12N 5/18 (2006.01); C07K 16/40 (2006.01); G01N 33/574 (2006.01); G01N 33/577 (2006.01); C12N 5/16 (2006.01); G01N 33/564 (2006.01); G01N 33/569 (2006.01); G01N 33/68 (2006.01); G01N 33/573 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/40 (2013.01); C07K 16/2896 (2013.01); C12N 5/163 (2013.01); G01N 33/564 (2013.01); G01N 33/56972 (2013.01); G01N 33/56983 (2013.01); G01N 33/573 (2013.01); G01N 33/574 (2013.01); G01N 33/577 (2013.01); G01N 33/57419 (2013.01); G01N 33/57423 (2013.01); G01N 33/57434 (2013.01); G01N 33/6893 (2013.01); A61K 2039/505 (2013.01); C07K 2317/24 (2013.01); C07K 2317/76 (2013.01); G01N 2333/70596 (2013.01); G01N 2333/948 (2013.01); G01N 2500/00 (2013.01); G01N 2800/042 (2013.01);
Abstract

It is intended to provide an anti-human CD26 antibody which permits analysis, etc., of the expression of CD26 in cancer tissues, immune tissues, or the like, for example, in order to select a patient applicable to treatment or to monitor therapeutic effects, and can also be used in immunostaining. The present invention relates to an anti-human CD26 monoclonal antibody or an antigen-binding fragment thereof, binding to an epitope which is recognized by a monoclonal antibody produced by a hybridoma deposited under Accession No. NITE BP-01642, a hybridoma deposited under Accession No. NITE BP-01643, or a hybridoma deposited under Accession No. NITE BP-01644.

Find Patent Forward Citations

Loading…